Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Predicting which children are at risk for ependymoma relapse.

Sowar K, Straessle J, Donson AM, Handler M, Foreman NK.

J Neurooncol. 2006 May;78(1):41-6. Epub 2006 Mar 31.

PMID:
16575538
2.

Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics.

Modena P, Lualdi E, Facchinetti F, Veltman J, Reid JF, Minardi S, Janssen I, Giangaspero F, Forni M, Finocchiaro G, Genitori L, Giordano F, Riccardi R, Schoenmakers EF, Massimino M, Sozzi G.

J Clin Oncol. 2006 Nov 20;24(33):5223-33.

PMID:
17114655
3.

Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysis.

Peyre M, Commo F, Dantas-Barbosa C, Andreiuolo F, Puget S, Lacroix L, Drusch F, Scott V, Varlet P, Mauguen A, Dessen P, Lazar V, Vassal G, Grill J.

PLoS One. 2010 Sep 24;5(9):e12932. doi: 10.1371/journal.pone.0012932.

4.

Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age.

Korshunov A, Neben K, Wrobel G, Tews B, Benner A, Hahn M, Golanov A, Lichter P.

Am J Pathol. 2003 Nov;163(5):1721-7.

5.

Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival.

Lukashova-v Zangen I, Kneitz S, Monoranu CM, Rutkowski S, Hinkes B, Vince GH, Huang B, Roggendorf W.

Acta Neuropathol. 2007 Mar;113(3):325-37. Epub 2007 Jan 31.

PMID:
17265049
6.

Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.

Mendrzyk F, Korshunov A, Benner A, Toedt G, Pfister S, Radlwimmer B, Lichter P.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2070-9.

7.

Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade.

Rousseau A, Idbaih A, Ducray F, Crinière E, Fèvre-Montange M, Jouvet A, Delattre JY.

J Neurooncol. 2010 May;97(3):353-64. doi: 10.1007/s11060-009-0039-6. Epub 2009 Oct 29.

PMID:
19865800
8.

Merlin expression in pediatric anaplastic ependymomas real time PCR study.

Buccoliero AM, Castiglione F, Rossi Degl'Innocenti D, Sardi I, Genitori L, Taddei GL.

Fetal Pediatr Pathol. 2010;29(4):245-54. doi: 10.3109/15513811003789644.

PMID:
20594149
9.

Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis.

de Bont JM, Kros JM, Passier MM, Reddingius RE, Sillevis Smitt PA, Luider TM, den Boer ML, Pieters R.

Neuro Oncol. 2008 Oct;10(5):648-60. doi: 10.1215/15228517-2008-032. Epub 2008 Jun 24.

10.

Immune gene and cell enrichment is associated with a good prognosis in ependymoma.

Donson AM, Birks DK, Barton VN, Wei Q, Kleinschmidt-Demasters BK, Handler MH, Waziri AE, Wang M, Foreman NK.

J Immunol. 2009 Dec 1;183(11):7428-40. doi: 10.4049/jimmunol.0902811. Epub 2009 Nov 16.

11.

Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group.

Robertson PL, Zeltzer PM, Boyett JM, Rorke LB, Allen JC, Geyer JR, Stanley P, Li H, Albright AL, McGuire-Cullen P, Finlay JL, Stevens KR Jr, Milstein JM, Packer RJ, Wisoff J.

J Neurosurg. 1998 Apr;88(4):695-703.

PMID:
9525716
12.

Region Specific Differences of Claudin-5 Expression in Pediatric Intracranial Ependymomas: Potential Prognostic Role in Supratentorial Cases.

Virág J, Haberler C, Baksa G, Piurkó V, Hegedüs Z, Reiniger L, Bálint K, Chocholous M, Kiss A, Lotz G, Glasz T, Schaff Z, Garami M, Hegedűs B.

Pathol Oncol Res. 2017 Apr;23(2):245-252. doi: 10.1007/s12253-016-0084-3. Epub 2016 Jul 9.

13.

Intracranial ependymoma: factors affecting outcome.

Massimino M, Buttarelli FR, Antonelli M, Gandola L, Modena P, Giangaspero F.

Future Oncol. 2009 Mar;5(2):207-16. doi: 10.2217/14796694.5.2.207. Review.

PMID:
19284379
14.

Predicting the recurrence of ependymomas from the bromodeoxyuridine labeling index.

Asai A, Hoshino T, Edwards MS, Davis RL.

Childs Nerv Syst. 1992 Aug;8(5):273-8.

PMID:
1394266
15.

[Pediatric ependymomas: Current diagnosis and therapy].

Frappaz D, Vasiljevic A, Beuriat PA, Alapetite C, Grill J, Szathmari A, Faure-Conter C.

Bull Cancer. 2016 Oct;103(10):869-879. doi: 10.1016/j.bulcan.2016.08.006. Epub 2016 Oct 4. French.

PMID:
27717499
16.

Tumor vessel biology in pediatric intracranial ependymoma.

Wagemakers M, Sie M, Hoving EW, Molema G, de Bont ES, den Dunnen WF.

J Neurosurg Pediatr. 2010 Apr;5(4):335-41. doi: 10.3171/2009.11.PEDS09260.

PMID:
20367336
17.

Novel fusion genes and chimeric transcripts in ependymal tumors.

Olsen TK, Panagopoulos I, Gorunova L, Micci F, Andersen K, Kilen Andersen H, Meling TR, Due-Tønnessen B, Scheie D, Heim S, Brandal P.

Genes Chromosomes Cancer. 2016 Dec;55(12):944-953. doi: 10.1002/gcc.22392. Epub 2016 Jul 28.

PMID:
27401149
18.

Preferential sites of metastatic relapse on MRI of initially localized ependymoma in children.

Rootman MS, Konen O, Fried I, Toledano H.

Clin Imaging. 2017 Jul - Aug;44:12-15. doi: 10.1016/j.clinimag.2017.03.015. Epub 2017 Mar 30.

PMID:
28395190
19.

Papillary Tumor of the Pineal Region: A Distinct Molecular Entity.

Heim S, Sill M, Jones DT, Vasiljevic A, Jouvet A, Fèvre-Montange M, Wesseling P, Beschorner R, Mittelbronn M, Kohlhof P, Hovestadt V, Johann P, Kool M, Pajtler KW, Korshunov A, Ruland V, Sperveslage J, Thomas C, Witt H, von Deimling A, Paulus W, Pfister SM, Capper D, Hasselblatt M.

Brain Pathol. 2016 Mar;26(2):199-205. doi: 10.1111/bpa.12282. Epub 2015 Jul 30.

PMID:
26113311
20.

Expression profiling of ependymomas unravels localization and tumor grade-specific tumorigenesis.

Palm T, Figarella-Branger D, Chapon F, Lacroix C, Gray F, Scaravilli F, Ellison DW, Salmon I, Vikkula M, Godfraind C.

Cancer. 2009 Sep 1;115(17):3955-68. doi: 10.1002/cncr.24476.

Supplemental Content

Support Center